Some space-constraining amino acid-containing oxytocin analogues were synthesized, of which the biological activities were found to be remarkably consistent with the predictions based on molecular mechanics calculations using the CHARMM program. Correlations of the biological activities and computer modeling studies of the conformational properties of Tyr², Phe², eBmp² (agonists), Pen¹, and Tic² (antagonists) oxytocin analogs revealed that a g+ conformation for the aromatic ring in the 2-position is important for the oxytocin-uterus receptor transduction. Examination of the topographical features of the energy minimized conformations of these analogs shows that a parallel aromatic surface over the top of the 20-membered disulfide containing...
The aim of this study was to investigate the molecular changes associated with the transition of the...
Oxytocin receptor mimetics were prepared by molecular imprinting using Z-oxytocin as the template. C...
The design and development of selective ligands for the human OT (oxytocin) and AVP (arginine vasopr...
The preparation of 11 new oxytocin analogs is described. The synthesis of the protected peptides wer...
The synthesis of seventeen novel conformationally constrained analogues of the neurohypophyseal pept...
This thesis describes the design, synthesis and pharmacological profile of a library of selective ox...
This thesis describes the design, synthesis and pharmacological evaluation of non-peptide based oxyt...
The nonapeptide oxytocin (OT) is used in medicine to help begin and/or continue childbirth. Its anal...
Oxytocin (OT) is an exciting potential therapeutic agent, but it is highly sensitive to modification...
Eleven oxytocin analogues substituted in position 4, 5 or 9 by tetrazole analogues of amino acids we...
A previously identified, non-peptidic oxytocin (OT) receptor agonist WAY-267,464 (1) and nine novel ...
The design and development of selective ligands for the human OT (oxytocin) and AVP (arginine vasopr...
The neurohypophyseal nonapeptide oxytocin (OT) is the main hormone responsible for the initiation of...
The neurohypophyseal nonapeptide oxytocin (OT) is the main hormone responsible for the initiation of...
AbstractNon-peptide antagonists of the oxytocin receptor (OTR) have been developed to prevent pre-te...
The aim of this study was to investigate the molecular changes associated with the transition of the...
Oxytocin receptor mimetics were prepared by molecular imprinting using Z-oxytocin as the template. C...
The design and development of selective ligands for the human OT (oxytocin) and AVP (arginine vasopr...
The preparation of 11 new oxytocin analogs is described. The synthesis of the protected peptides wer...
The synthesis of seventeen novel conformationally constrained analogues of the neurohypophyseal pept...
This thesis describes the design, synthesis and pharmacological profile of a library of selective ox...
This thesis describes the design, synthesis and pharmacological evaluation of non-peptide based oxyt...
The nonapeptide oxytocin (OT) is used in medicine to help begin and/or continue childbirth. Its anal...
Oxytocin (OT) is an exciting potential therapeutic agent, but it is highly sensitive to modification...
Eleven oxytocin analogues substituted in position 4, 5 or 9 by tetrazole analogues of amino acids we...
A previously identified, non-peptidic oxytocin (OT) receptor agonist WAY-267,464 (1) and nine novel ...
The design and development of selective ligands for the human OT (oxytocin) and AVP (arginine vasopr...
The neurohypophyseal nonapeptide oxytocin (OT) is the main hormone responsible for the initiation of...
The neurohypophyseal nonapeptide oxytocin (OT) is the main hormone responsible for the initiation of...
AbstractNon-peptide antagonists of the oxytocin receptor (OTR) have been developed to prevent pre-te...
The aim of this study was to investigate the molecular changes associated with the transition of the...
Oxytocin receptor mimetics were prepared by molecular imprinting using Z-oxytocin as the template. C...
The design and development of selective ligands for the human OT (oxytocin) and AVP (arginine vasopr...